Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving

Author: Henry Khederian | December 05, 2023 11:22am

SpringWorks Therapeutics Inc (NASDAQ:SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a public offering.

This offering involves selling approximately 9.48 million shares of its common stock at $29.00 per share, totaling an expected gross proceeds of about $275.0 million before expenses. The company expects to close the offering around December 7, pending standard closing conditions.

Additionally, SpringWorks has granted underwriters an option to purchase an additional 1.42 million shares within 30 days at the same offering price, minus discounts and commissions.

See Also: SpringWorks Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

According to data from Benzinga Pro, SWTX has a 52-week high of $34.16 and a 52-week low of $18.00.

Posted In: SWTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist